BiomX
PHGE
9 hedge funds and large institutions have $2.77M invested in BiomX in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.
44% more capital invested
Capital invested by funds: $1.93M → $2.77M (+$843K)
0.01% less ownership
Funds ownership: 0.1% → 0.09% (-0.01%)
25% less funds holding
Funds holding: 12 → 9 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$425K |
| 2 |
Renaissance Technologies
New York
|
+$35.8K |
| 3 |
VF
Virtu Financial
New York
|
+$16.5K |
| 4 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$11.1K |
| 5 |
Millennium Management
New York
|
+$3.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$59.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$9.29K |
| 3 |
BlackRock
New York
|
-$1.75K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$916 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $1.64M | +$425K | +7,327 | +44% |
|
|
JJ
2
Johnson & Johnson
New Brunswick,
New Jersey
| $768K | – | – | – |
|
|
MI
3
MMCAP International
Grand Cayman,
Cayman Islands
| $232K | +$11.1K | +191 | +6% |
|
|
4
Renaissance Technologies
New York
| $70K | +$35.8K | +617 | +150% |
|
|
VF
5
Virtu Financial
New York
| $19K | +$16.5K | +284 | New |
|
|
BCM
6
Bridgeway Capital Management
Houston,
Texas
| $17.8K | – | – | – |
|
|
7
Millennium Management
New York
| $16.5K | +$3.83K | +66 | +38% |
|
8
Walleye Capital
New York
| $7.58K | – | – | – |
|
9
Walleye Trading
New York
| $3.75K | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$59.7K | -1,029 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$9.29K | -160 | Closed |
|
|
12
BlackRock
New York
| – | -$1.75K | -30 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$916 | -16 | Closed |
|
PHGE Hedge Fund Activity: Q2 2023 in Review
9 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q2 2023, worth a combined $2.77M — up 44% from $1.93M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PHGE and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was OrbiMed, adding an estimated $425K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $59.7K sold.
- 9 institutional investors held BiomX (PHGE) as of Q2 2023, down from 12 in Q1 2023.
- Funds reported $2.77M of BiomX stock for Q2 2023, up 44% quarter-over-quarter.
- 1 fund opened new BiomX positions in Q2 2023 and 4 closed out, a net change of -3 holders.
- The largest BiomX buyer in Q2 2023 was OrbiMed, an estimated $425K added.
- The largest BiomX seller in Q2 2023 was Susquehanna International Group, an estimated $59.7K sold.
Based on aggregated 13F filings for Q2 2023.